Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00780182 · ClinicalTrials.gov registry record · Phase 1
Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers
A Phase 1 study, sponsored by Jazz Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00780182 is a Phase 1 study that has completed, run by Jazz Pharmaceuticals. The registered enrollment target is 24 participants.
The verdict
NCT00780182, a Phase 1 study, has completed, sponsored by Jazz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the bioavailability of CMX001 when administered as a tablet vs a solution and to determine the effect of a high-fat meal on CMX001 bioavailability.
Interventions
- DRUG CMX001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00780182
The ClinicalTrials.gov registry entry for NCT00780182 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CMX001 is the first listed.
NCT00780182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00780182 about?
NCT00780182 is a clinical study titled "Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers". The purpose of this study is to compare the bioavailability of CMX001 when administered as a tablet vs a solution and to determine the effect of a high-fat meal on CMX001 bioavailability.
What is the current status of trial NCT00780182?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-10. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00780182?
The interventions under investigation include: CMX001 (DRUG).
Who is sponsoring clinical trial NCT00780182?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.